Literature DB >> 16503582

Influence of surface anesthesia on the pressure pain threshold measured with different-sized probes.

Ken Takahashi1, Toru Taguchi, Kazunori Itoh, Kaoru Okada, Kenji Kawakita, Kazue Mizumura.   

Abstract

Transcutaneous pressure with pressure probes of arbitrary diameters have been commonly used for measuring the threshold and magnitude of muscle pain, yet this procedure lacks scientific validation. To examine the valid probe dimensions, we conducted physiological experiments using 34 human subjects. Pin-prick pain, pressure pain threshold (PPT) to pressure probes of various diameters, heat pain threshold, and electrical pain threshold of deep tissues were measured before and after application of surface lidocaine anesthesia to the skin surface over the brachioradial muscle in a double-blinded manner. The anesthesia neither affected PPT with larger probes (diameters: 1.6 and 15 mm) nor increased electric pain threshold of deep structures, whereas it diminished pain count in pin-prick test and PPT with a 1.0 mm diameter probe, suggesting that mechanical pain thresholds measured with 1.6 and 15 mm probes reflect the pain threshold of deep tissues, possibly muscle. Pain thresholds to heat did not change after application of the anesthesia. These results suggest that larger pressure probes can give a better estimation of muscular pain threshold.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16503582     DOI: 10.1080/08990220500420475

Source DB:  PubMed          Journal:  Somatosens Mot Res        ISSN: 0899-0220            Impact factor:   1.111


  22 in total

1.  Tissue characteristics during temporal summation of pressure-evoked pain.

Authors:  Sara Finocchietti; Lars Arendt-Nielsen; Thomas Graven-Nielsen
Journal:  Exp Brain Res       Date:  2012-04-05       Impact factor: 1.972

2.  An MRI-based leg model used to simulate biomechanical phenomena during cuff algometry: a finite element study.

Authors:  Bahram Manafi-Khanian; Lars Arendt-Nielsen; Thomas Graven-Nielsen
Journal:  Med Biol Eng Comput       Date:  2015-04-28       Impact factor: 2.602

3.  Further validation of a model of fibromyalgia syndrome in the rat.

Authors:  Paul G Green; Pedro Alvarez; Robert W Gear; Dennis Mendoza; Jon D Levine
Journal:  J Pain       Date:  2011-04-09       Impact factor: 5.820

4.  IB4-saporin attenuates acute and eliminates chronic muscle pain in the rat.

Authors:  Pedro Alvarez; Robert W Gear; Paul G Green; Jon D Levine
Journal:  Exp Neurol       Date:  2011-12-27       Impact factor: 5.330

Review 5.  Delayed onset muscle soreness: Involvement of neurotrophic factors.

Authors:  Kazue Mizumura; Toru Taguchi
Journal:  J Physiol Sci       Date:  2016-01       Impact factor: 2.781

6.  Muscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathy.

Authors:  Pedro Alvarez; Luiz F Ferrari; Jon D Levine
Journal:  Ann Neurol       Date:  2011-07       Impact factor: 10.422

7.  Upregulated glial cell line-derived neurotrophic factor through cyclooxygenase-2 activation in the muscle is required for mechanical hyperalgesia after exercise in rats.

Authors:  Shiori Murase; Etsuji Terazawa; Kenji Hirate; Hiroki Yamanaka; Hirosato Kanda; Koichi Noguchi; Hiroki Ota; Fernando Queme; Toru Taguchi; Kazue Mizumura
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

8.  Effects of local anesthetics on somatosensory function in the temporomandibular joint area.

Authors:  Emad E Ayesh; Malin Ernberg; Peter Svensson
Journal:  Exp Brain Res       Date:  2007-02-15       Impact factor: 1.972

9.  A dual role for peripheral GDNF signaling in nociception and cardiovascular reflexes in the mouse.

Authors:  Luis F Queme; Alex A Weyler; Elysia R Cohen; Renita C Hudgins; Michael P Jankowski
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-17       Impact factor: 11.205

10.  Effects of tender point acupuncture on delayed onset muscle soreness (DOMS)--a pragmatic trial.

Authors:  Kazunori Itoh; Hideki Ochi; Hiroshi Kitakoji
Journal:  Chin Med       Date:  2008-11-25       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.